Avalo Therapeutics, Inc. (AVTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
4:07 pm
Sale
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
BIOTECHNOLOGY VALUE FUND L P907,406
1.700%
-1,894,139decrease
(-67.61%)
Filing
History
2026-11-16
4:07 pm
Sale
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
Point72 Asset Management, L.P.1,625,019
3.000%
-1,085,798decrease
(-40.05%)
Filing
History
2026-11-13
08:48 am
Purchase
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
Farallon Capital Management, L.L.C.3,974,000
7.400%
3,974,000increase
(New Position)
Filing
History
2026-11-10
06:36 am
Sale
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
STATE STREET CORP
STT
2,563,226
4.800%
-326,061decrease
(-11.29%)
Filing
History
2026-11-06
09:45 am
Sale
2026-10-3013GAVALO THERAPEUTICS INC PAR
AVTX
FMR LLC474,359
0.900%
-4,775,822decrease
(-90.96%)
Filing
History
2026-11-05
1:10 pm
Sale
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
FMR LLC5,250,181
9.800%
-487,785decrease
(-8.50%)
Filing
History
2026-10-29
4:15 pm
Purchase
2026-10-2213GAVALO THERAPEUTICS INC PAR
AVTX
Trails Edge Capital Partners, LP2,803,761
5.200%
2,803,761increase
(New Position)
Filing
History
2026-08-14
4:40 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
Nantahala Capital Management, LLC1,862,250
3.540%
627,250increase
(+50.79%)
Filing
History
2026-08-14
4:40 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
Caligan Partners LP3,163,866
5.900%
1,528,843increase
(+93.51%)
Filing
History
2026-08-14
4:38 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
RA CAPITAL MANAGEMENT L.P.3,483,099
6.300%
1,027,444increase
(+41.84%)
Filing
History
2026-08-14
4:01 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
BIOTECHNOLOGY VALUE FUND L P2,801,545
5.300%
453,700increase
(+19.32%)
Filing
History
2026-08-14
10:39 am
Sale
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
T. Rowe Price Investment Management, Inc.3,670
0.000%
-2,159,014decrease
(-99.83%)
Filing
History
2026-08-14
09:00 am
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
Avoro Capital Advisors LLC2,333,333
4.440%
923,333increase
(+65.48%)
Filing
History
2026-08-14
08:24 am
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
Deep Track Capital, LP3,610,000
6.870%
554,973increase
(+18.17%)
Filing
History
2026-08-13
4:06 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
Affinity Asset Advisors, LLC2,900,000
5.500%
1,559,160increase
(+116.28%)
Filing
History
2026-08-07
11:04 am
Purchase
2026-07-3113GAVALO THERAPEUTICS INC PAR
AVTX
FMR LLC5,737,966
10.800%
637,750increase
(+12.50%)
Filing
History
2026-08-07
08:44 am
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
STATE STREET CORP
STT
2,889,287
5.500%
2,889,287increase
(New Position)
Filing
History
2026-08-06
10:14 am
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
FMR LLC5,100,216
9.700%
1,911,815increase
(+59.96%)
Filing
History
2026-07-27
4:25 pm
Purchase
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
BlackRock Inc.
BLK
3,415,731
6.500%
3,415,731increase
(New Position)
Filing
History
2026-07-06
5:29 pm
Sale
2026-06-3013GAVALO THERAPEUTICS INC PAR
AVTX
MILLENNIUM MANAGEMENT LLC9,857
0.000%
-924,572decrease
(-98.95%)
Filing
History
Goto 0, 1, 2, 3, 4, Next